Medium materiality6/10
Dyne Therapeutics price target lowered to $26 from $30 at Baird
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Baird lowers DYN target to $26; current price $20.31; upside remains to reach target.
- Target cut to $26; price $20.31; upside remains.
Key facts
- 01
Target: $26
- 02
Posted price: $20.31
- 03
Analyst firm: Robert W. Baird
- 04
Analyst: Brian Skorney
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.